Mar 07, 2026, 12:58 AM IST RRP Defense - Announcement under Regulation 30 (LODR)-Change in Registered Office Address Mar 07, 2026, 12:54 AM IST RRP Defense - Board Meeting Outcome for Outcome Of The ...
This beginner-friendly tutorial shows how to create clear, interactive graphs in GlowScript VPython. You’ll learn the basics of setting up plots, graphing data in real time, and customizing axes and ...
https://www.thehindubusinessline.com/companies/rrp-semiconductors-70000-stock-surge-likely-rests-on-shell-entities-and-a-fishy-corporate-trail/article70314816.ece ...
Open a Notepad and copy-paste the following: Set WshShell = CreateObject("WScript.Shell") MsgBox ConvertToKey(WshShell.RegRead("HKLM\SOFTWARE\Microsoft\Windows NT\CurrentVersion\DigitalProductId")) ...
Mumbai: Bombay Stock Exchange (BSE) has imposed a new weekly trading surveillance measure on nine stocks, including RRP Semiconductors, to address excessive volatility following unusual price ...
BSE has imposed new surveillance measures on nine stocks, including RRP Semiconductors, which has recently been in the news for its unusual price run. In a circular issued on Friday, BSE stated: “In ...
RRP Semiconductor on October 14 clarified former cricketer Sachin Tendulkar hasn't subscribed to any of its shares and is not its brand ambassador. The clarification comes in wake of "unprecedented ...
On 14 August 2025, the US Food and Drugs Administration (FDA) approved Precigen’s Papzimeos (zopapogene imadenovec) for recurrent respiratory papillomatosis (RRP) - the first FDA-approved therapy for ...
Inovio Pharmaceuticals (INO) had a slight setback with its timeline on when it could actually file its Biologics License Application [BLA] of INO-3107 for the treatment of patients with recurrent ...
In related developments, JMP Securities maintained its Market Outperform rating and $6 price target on Precigen Inc., following a patient advocacy event for RRP. The event, which was hosted by the ...
FORT WORTH, Texas--(BUSINESS WIRE)--The Recurrent Respiratory Papillomatosis Foundation (RRPF) is excited to share the news that the U.S. Food and Drug Administration (FDA) has granted full approval ...